IN2013MU00985A - - Google Patents

Download PDF

Info

Publication number
IN2013MU00985A
IN2013MU00985A IN985MU2013A IN2013MU00985A IN 2013MU00985 A IN2013MU00985 A IN 2013MU00985A IN 985MU2013 A IN985MU2013 A IN 985MU2013A IN 2013MU00985 A IN2013MU00985 A IN 2013MU00985A
Authority
IN
India
Prior art keywords
provides
composition
therapeutic agents
present
delivery
Prior art date
Application number
Other languages
English (en)
Inventor
Banerjee Prof Rinti
Guha Sarkar Shruti
Original Assignee
Indian Inst Technology Bombay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indian Inst Technology Bombay filed Critical Indian Inst Technology Bombay
Priority to IN985MU2013 priority Critical patent/IN2013MU00985A/en
Publication of IN2013MU00985A publication Critical patent/IN2013MU00985A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN985MU2013 2013-03-22 2013-03-22 IN2013MU00985A (enExample)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN985MU2013 IN2013MU00985A (enExample) 2013-03-22 2013-03-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN985MU2013 IN2013MU00985A (enExample) 2013-03-22 2013-03-22

Publications (1)

Publication Number Publication Date
IN2013MU00985A true IN2013MU00985A (enExample) 2015-05-29

Family

ID=54395121

Family Applications (1)

Application Number Title Priority Date Filing Date
IN985MU2013 IN2013MU00985A (enExample) 2013-03-22 2013-03-22

Country Status (1)

Country Link
IN (1) IN2013MU00985A (enExample)

Similar Documents

Publication Publication Date Title
PH12019502018A1 (en) Compositions, formulations and methods for treating ocular diseases
ZA202004764B (en) Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
MY189979A (en) Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease
EP3122878A4 (en) Mrna therapy for the treatment of ocular diseases
TW201613901A (en) New compounds
GT201200315A (es) Agentes inductores de apoptosis para el tratamiento del cáncer y de enfermedades inmunes y autoinmunes
PH12013500577A1 (en) Compositions and methods for treating ocular edema, neovascularization and related diseases
NZ707086A (en) Anti-cd40 antibodies and methods of use
GB201118656D0 (en) New compounds
CL2018000597A1 (es) Métodos para tratar enfermedades inflamatorias
SG194701A1 (en) Anti-cd40 antibodies and methods of use
PH12014500967A1 (en) A medicament for treating anterior eye disease comprising rebamipide and a tear-retaining agent
PH12017500809B1 (en) Improved il-6 antibodies
MX349224B (es) Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa.
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
GB201213484D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods of using the same
EA201690191A1 (ru) Фармацевтическая композиция для замедленного высвобождения ланреотида
BR112017007916A2 (pt) compostos sarms para tratamento de distúrbios urológicos
PH12014502065A1 (en) Vesicular formulations
MX2020003427A (es) Agentes terapeuticos para enfermedades neurodegenerativas.
IN2013MU00985A (enExample)
WO2012123561A3 (de) Agens zur prophylaxe und behandlung altersassoziierter krankheiten und störungen sowie zur verlängerung der lebensdauer
NZ623275A (en) Treatment of ocular disease